Home > Products > CD20 & CD22
> Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Triple Body)
Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Triple Body) (CAT#: TRIB-049)
Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD20 antibody are both extended with the scFv fragment from an anti-CD22 antibody. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Triple Body) (TRIB-049). Click the button below to contact us or submit your feedback about this product.